These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24211266)

  • 1. An MRAS, SHOC2, and SCRIB complex coordinates ERK pathway activation with polarity and tumorigenic growth.
    Young LC; Hartig N; Muñoz-Alegre M; Oses-Prieto JA; Durdu S; Bender S; Vijayakumar V; Vietri Rudan M; Gewinner C; Henderson S; Jathoul AP; Ghatrora R; Lythgoe MF; Burlingame AL; Rodriguez-Viciana P
    Mol Cell; 2013 Dec; 52(5):679-92. PubMed ID: 24211266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHOC2-MRAS-PP1 complex positively regulates RAF activity and contributes to Noonan syndrome pathogenesis.
    Young LC; Hartig N; Boned Del Río I; Sari S; Ringham-Terry B; Wainwright JR; Jones GG; McCormick F; Rodriguez-Viciana P
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10576-E10585. PubMed ID: 30348783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SHOC2 complex-driven RAF dimerization selectively contributes to ERK pathway dynamics.
    Boned Del Río I; Young LC; Sari S; Jones GG; Ringham-Terry B; Hartig N; Rejnowicz E; Lei W; Bhamra A; Surinova S; Rodriguez-Viciana P
    Proc Natl Acad Sci U S A; 2019 Jul; 116(27):13330-13339. PubMed ID: 31213532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRAS: A Close but Understudied Member of the RAS Family.
    Young LC; Rodriguez-Viciana P
    Cold Spring Harb Perspect Med; 2018 Dec; 8(12):. PubMed ID: 29311130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the SHOC2-MRAS-PP1C complex provides insights into RAF activation and Noonan syndrome.
    Bonsor DA; Alexander P; Snead K; Hartig N; Drew M; Messing S; Finci LI; Nissley DV; McCormick F; Esposito D; Rodriguez-Viciana P; Stephen AG; Simanshu DK
    Nat Struct Mol Biol; 2022 Oct; 29(10):966-977. PubMed ID: 36175670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
    Jones GG; Del Río IB; Sari S; Sekerim A; Young LC; Hartig N; Areso Zubiaur I; El-Bahrawy MA; Hynds RE; Lei W; Molina-Arcas M; Downward J; Rodriguez-Viciana P
    Nat Commun; 2019 Jun; 10(1):2532. PubMed ID: 31182717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the MRAS-SHOC2-PP1C phosphatase complex.
    Hauseman ZJ; Fodor M; Dhembi A; Viscomi J; Egli D; Bleu M; Katz S; Park E; Jang DM; Porter KA; Meili F; Guo H; Kerr G; Mollé S; Velez-Vega C; Beyer KS; Galli GG; Maira SM; Stams T; Clark K; Eck MJ; Tordella L; Thoma CR; King DA
    Nature; 2022 Sep; 609(7926):416-423. PubMed ID: 35830882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The scaffold protein Shoc2/SUR-8 accelerates the interaction of Ras and Raf.
    Matsunaga-Udagawa R; Fujita Y; Yoshiki S; Terai K; Kamioka Y; Kiyokawa E; Yugi K; Aoki K; Matsuda M
    J Biol Chem; 2010 Mar; 285(10):7818-26. PubMed ID: 20051520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function analysis of the SHOC2-MRAS-PP1C holophosphatase complex.
    Kwon JJ; Hajian B; Bian Y; Young LC; Amor AJ; Fuller JR; Fraley CV; Sykes AM; So J; Pan J; Baker L; Lee SJ; Wheeler DB; Mayhew DL; Persky NS; Yang X; Root DE; Barsotti AM; Stamford AW; Perry CK; Burgin A; McCormick F; Lemke CT; Hahn WC; Aguirre AJ
    Nature; 2022 Sep; 609(7926):408-415. PubMed ID: 35831509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insights into the role of SHOC2-MRAS-PP1C complex in RAF activation.
    Bonsor DA; Simanshu DK
    FEBS J; 2023 Oct; 290(20):4852-4863. PubMed ID: 37074066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M-Ras/Shoc2 signaling modulates E-cadherin turnover and cell-cell adhesion during collective cell migration.
    Kota P; Terrell EM; Ritt DA; Insinna C; Westlake CJ; Morrison DK
    Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3536-3545. PubMed ID: 30808747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for SHOC2 modulation of RAS signalling.
    Liau NPD; Johnson MC; Izadi S; Gerosa L; Hammel M; Bruning JM; Wendorff TJ; Phung W; Hymowitz SG; Sudhamsu J
    Nature; 2022 Sep; 609(7926):400-407. PubMed ID: 35768504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shoc2/Sur8 protein regulates neurite outgrowth.
    Leon G; Sanchez-Ruiloba L; Perez-Rodriguez A; Gragera T; Martinez N; Hernandez S; Anta B; Calero O; Garcia-Dominguez CA; Dura LM; Peña-Jimenez D; Castro J; Zarich N; Sanchez-Gomez P; Calero M; Iglesias T; Oliva JL; Rojas JM
    PLoS One; 2014; 9(12):e114837. PubMed ID: 25514808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors.
    Lai LP; Fer N; Burgan W; Wall VE; Xu B; Soppet D; Esposito D; Nissley DV; McCormick F
    Proc Natl Acad Sci U S A; 2022 Feb; 119(5):. PubMed ID: 35091470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating MRAS mutations cause Noonan syndrome associated with hypertrophic cardiomyopathy.
    Motta M; Sagi-Dain L; Krumbach OHF; Hahn A; Peleg A; German A; Lissewski C; Coppola S; Pantaleoni F; Kocherscheid L; Altmüller F; Schanze D; Logeswaran T; Chahrokh-Zadeh S; Munzig A; Nakhaei-Rad S; Cavé H; Ahmadian MR; Tartaglia M; Zenker M
    Hum Mol Genet; 2020 Jul; 29(11):1772-1783. PubMed ID: 31108500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of the Drosophila cell polarity regulator Scribbled promotes epithelial tissue overgrowth and cooperation with oncogenic Ras-Raf through impaired Hippo pathway signaling.
    Doggett K; Grusche FA; Richardson HE; Brumby AM
    BMC Dev Biol; 2011 Sep; 11():57. PubMed ID: 21955824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
    Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
    Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shoc2 is targeted to late endosomes and required for Erk1/2 activation in EGF-stimulated cells.
    Galperin E; Abdelmoti L; Sorkin A
    PLoS One; 2012; 7(5):e36469. PubMed ID: 22606262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phosphatase holoenzyme comprised of Shoc2/Sur8 and the catalytic subunit of PP1 functions as an M-Ras effector to modulate Raf activity.
    Rodriguez-Viciana P; Oses-Prieto J; Burlingame A; Fried M; McCormick F
    Mol Cell; 2006 Apr; 22(2):217-30. PubMed ID: 16630891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective.
    Kwon JJ; Hahn WC
    Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.